Crestchem Limited (BOM:526269)
88.00
-1.50 (-1.68%)
At close: Jan 21, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 261 million as of January 23, 2026. Its market cap has decreased by -69.03% in one year.
Market Cap
261.00M
Enterprise Value
250.54M
Revenue
242.52M
Ranking
n/a
PE Ratio
12.89
Stock Price
88.00
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 261.00M, an increase of 735.73%. That is a compound annual growth rate of 17.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 261.00M | -22.63% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auro Laboratories | 1.34B |
| Krebs Biochemicals & Industries | 1.30B |
| Tyche Industries | 1.18B |
| Resonance Specialties | 1.15B |
| Bacil Pharma | 637.42M |
| Vasundhara Rasayans | 475.94M |
| Supha Pharmachem | 342.72M |
| Ishita Drugs and Industries | 209.32M |